Clinical Trial Update: TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2, single-arm clinical trial assessing the TC regimen as adjuvant therapy after surgery for locally recurrent resectable nasopharyngeal carcinoma; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• TC regimen

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 2 | Status: NOT_YET_RECRUITING